SCHEMBL4690929

SCHEMBL4690929

COc1cc2c(NC(=S)Nc3c(C)cccc3C)ncnc2cc1OCc1ccccn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.60
ERBB2 P04626 2/20 0.60
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 2/20 0.50
KDR P35968 5/20 0.48
RET P07949 5/20 0.48
KIF5B P33176 3/20 0.48
FGFR1 P11362 2/20 0.48
FLT1 P17948 2/20 0.48
CDK2 P24941 1/20 0.48
PIK3R1 P27986 1/20 0.48
EPHB2 P29323 1/20 0.48
TTBK1 Q5TCY1 1/20 0.48
ERBB4 Q15303 1/20 0.48
NOD1 Q9Y239 1/20 0.48
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689455 0.89 EGFR (0.58) EGFRALDH1A1HPGDHTTKDR
SCHEMBL5828725 0.85 FLT1 (0.62) EGFRERBB2ALDH1A1HPGDHTT
SCHEMBL5832489 0.85 FLT1 (0.62) EGFRERBB2ALDH1A1HPGDHTT
SCHEMBL4689960 0.83 FLT1 (0.59) EGFRERBB2ALDH1A1HPGDHTT
SCHEMBL4689353 0.83 KDR (0.55) EGFRERBB2KDRRETKIF5B
SCHEMBL4689400 0.83 FLT1 (0.59) EGFRERBB2ALDH1A1HPGDHTT
SCHEMBL5827938 0.81 RET (0.45) EGFRERBB2ALDH1A1HPGDHTT
SCHEMBL4689828 0.80 RET (0.60) EGFRKDRRETKIF5BFGFR1
SCHEMBL4693034 0.80 RET (0.59) ERBB2KDRRETKIF5B
SCHEMBL4690872 0.79 EGFR (0.58) EGFRERBB2KDRRETKIF5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed